Gender-affirming hormone therapy resolves conflicts between gender identity and secondary sexual characteristics in transgender people.A new cross-sectional study emphasizes that people who have been receiving this therapy report its positive effect on their lives.
The 142 Portuguese participants in the study had all been receiving hormone therapy for at least a year.Dr. Miguel Saraiva, endocrinologist at Centro Hospitalar Universitário do Porto – Hospital de Santo António, Portugal, told Medical News Today: “We have to understand that being transgender is not an illness. As cisgender people do, transgender people also know who they are. It is their identity and one can not change that.”
“We have to start listening to these patients and educate ourselves about their health needs and about gender-affirming medical interventions,” he stressed.In late May 2022, Dr. Saraiva presented his research at the European Congress of Endocrinology in Milan, Italy regarding the value of gene-affirming hormone therapy.
An increasing number of transgender and nonbinary people, according to Dr. Saraiva, have been seeking treatment to resolve conflicts between their gender identity and the sex assigned to them at birth.The Portuguese researchers found that people who had undergone gene-affirming hormone therapy reported high levels of satisfaction with the psychological and physiological results.
Dr. Saraiva noted that “[t]his therapy seems to significantly enhance self-esteem, body well-being, and social/ familial relations and to reduce suicidal ideation, having an overall great impact on the quality of life.”
BEZZY COMMUNITY Meet Bezzy for Depression, a community that cares Find encouragement and support through 1-1 messaging and advice from others dealing with major depressive disorder.
Gender dysphoria The National Health Service in the United Kingdom describes gender dysphoria as the “sense of unease that a person may have because of a mismatch between their biological sex and their gender identity.”
Gender dysphoria is increasingly commonTrusted Source among adolescents. And according to one 2019 studyTrusted Source, “[g]ender dysphoric patients are at significant risk for psychiatric comorbidities and suicidal ideation and attempts.”
“It is crucial that primary care providers be aware of and diligently evaluate these risks, regardless of treatment status. A collaborative, multidisciplinary approach can help care for this vulnerable population and avoid tragic outcomes,” the study emphasizes.
